Approval · Notice of Compliance 20692 · 2018
DEXTROAMPHETAMINE: Notice of Compliance 20692
Issued April 4, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20692
- Date
- April 4, 2018
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in Product Ownership Revisions to the product monograph and labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DEXTROAMPHETAMINE | 02443236 | Marketed |
Medicinal ingredients
- DEXTROAMPHETAMINE SULFATE 5 MG per TAB